Welcome to our iboga eStore, a premier source for high-purity ibogaine alkaloids and iboga botanical derivatives across Germany and the European Union. We ship certified reference materials directly to laboratories. Toxicologists, researchers, and individuals seeking precise harm-reduction data rely on our catalog.
Ibogaine, the main alkaloid extracted from the root bark of the Tabernanthe iboga shrub, remains a focal point of neuropharmacological study. Its complex interaction with the central nervous system is remarkable. Rather than mimicking traditional interventions, this compound acts directly on dopaminergic, glutamatergic, and neurotrophic pathways. This action helps reset troubled mesocorticolimbic pathways. Thus, it holds relevance for investigations into chemical dependency, trauma, obsessive states, and related reward-loop dysfunction.
Here, uncompromising quality, chemical verification, and absolute discretion govern our operations. Every batch undergoes independent laboratory testing. We verify alkaloid concentration and screen out impurities, making verified, reliable materials available for your analytical and educational projects.
A fully equipped setup tailored for orderly analysis or safer-use protocols. You can select either the Single Substance or the Multi-Substance pathway.
The definitive reference point for iboga alkaloid purity. This is the isolated, standalone molecule, offering a reliable concentration ranging from 61% to 99.65%. It remains the most thoroughly researched variant, backed by robust clinical data.
A complete, whole-plant extract that retains the full suite of native iboga alkaloids. It features ibogaine alongside ibogaline, ibogamine, and a host of naturally co-occurring helper compounds that work together.
This variant strikes a perfect middle ground, pairing whole-plant complexity with refined concentration. You get nearly 73.7% ibogaine content while keeping 10% to 40% of the naturally co-occurring companion alkaloids intact.
Carefully portioned Ibogaine HCl capsules designed for exact, fuss-free administration. Forget the scales and calibration—these are prepared and set to go.
The ancestral preparation of iboga, mirroring the raw bark harvested for generations in traditional West African spiritual rites. Completely raw and unrefined botanical matter.
Time-tested root bark powder, pre-divided into straightforward, easy-to-take gelatin shells.
This Total Alkaloid (TA) concentrate carries the entire molecular blueprint found in raw Tabernanthe iboga root bark. You aren’t just getting isolated ibogaine. Instead, you get ibogaline, ibogamine, and the trace alkaloids that naturally occur alongside them. Isolated Ibogaine HCl strips everything else away.
Our Ibogaine HCl consistently yields between 61% and 73% active purity. This is the exact metric required for data replication. To prove it, third-party, certified testing facilities vet every single batch we ship.
We supply everything from highly isolated HCl salts to raw, traditional root bark. This ensures your specific laboratory model has the exact chemical profile it demands.
We ship in completely plain, unbranded parcels. Climate-regulated. Fully monitored.
Our team compiles detailed experimental manuals, step-by-step safety measures, and chemical comparison charts. We want your laboratory team to have deep, clear background data.
We publish exhaustive risk profiles alongside interactive contraindication checklists. Furthermore, we mandate that researchers verify ECG screening protocols prior to starting any trial.
Neurologists pay close attention to how ibogaine influences complex brain pathways. Current clinical models indicate that its multi-targeted actions—specifically triggering GDNF expression, balancing glutamate and dopamine levels, and resetting neuroplasticity windows—might operate as a singular, unified pathway. This could recalibrate deep-seated reward circuitry when it has been compromised.
In vitro and animal trials reveal that ibogaine behaves nothing like standard detox molecules. It targets dopamine transport systems, alters glutamatergic signaling, and sparks the production of glial cell line-derived neurotrophic factor (GDNF). This rare, multi-layered chemical behavior explains why modern laboratories are so eager to study the molecule.
Global markets for psychedelic-assisted medicine stood at $5.49 billion in 2025. Analysts expect this figure to surge to around $18.2 billion by 2034. Germany sits right at the center of this expanding landscape, with local academic institutions rapidly ramping up clinical trials involving ibogaine.
05Aug
06Aug
07Aug
08Aug
English English 
Deutsch
Français
Dansk
Polski
by